Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
暂无分享,去创建一个
Luca Laurenti | Raul Rabadan | Silvia Deaglio | Robin Foà | Davide Rossi | Laura Pasqualucci | Giulia Fabbri | Riccardo Dalla-Favera | Silvia Rasi | L. Pasqualucci | R. Rabadán | R. Foà | G. Fabbri | D. Rossi | G. Gaidano | A. Guarini | R. Marasca | S. Deaglio | D. Capello | S. Rasi | S. Monti | V. Gattei | L. Laurenti | Gianluca Gaidano | Daniela Capello | Francesco Forconi | F. Forconi | Anna Guarini | Valter Gattei | Roberto Marasca | L. De Paoli | V. Spina | A. Bruscaggin | M. Cerri | P. Bulian | R. Famà | Lorenzo De Paoli | Michaela Cerri | Sara Monti | Valeria Spina | Alessio Bruscaggin | Rosella Famà | Stefania Cresta | M. Fangazio | Marco Fangazio | Pietro Bulian | S. Cresta | R. Dalla-Favera | Marco Fangazio | Rosella Famà
[1] Š. Pospíšilová,et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. , 2009, Blood.
[2] K. Maloum,et al. Chlorambucil in Indolent Chronic Lymphocytic Leukemia , 1998 .
[3] J. Aster,et al. Notch signalling in T‐cell lymphoblastic leukaemia/lymphoma and other haematological malignancies , 2011, The Journal of pathology.
[4] Axel Benner,et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. , 2008, Blood.
[5] ONSTANZE,et al. GENOMIC ABERRATIONS AND SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA , 2010 .
[6] Douglas G Altman,et al. Reporting recommendations for tumor marker prognostic studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Michael Schemper,et al. The explained variation in proportional hazards regression , 1990 .
[8] I. Screpanti,et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. , 2009, Blood.
[9] D. Rossi,et al. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia , 2011, Hematological oncology.
[10] D C Case,et al. Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.
[11] A. Pettitt,et al. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia , 2007, Leukemia.
[12] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[13] A. Ng,et al. Diffuse large B-cell lymphoma. , 2007, Seminars in radiation oncology.
[14] E. Steyerberg,et al. [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.
[15] E. Montserrat,et al. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. , 1988, Nouvelle revue francaise d'hematologie.
[16] C. C. Chen,et al. The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. , 1985, Statistics in medicine.
[17] L. Pasqualucci,et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation , 2011, The Journal of experimental medicine.
[18] S. Pileri,et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. , 2011, Blood.
[19] A. Ferrando,et al. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. , 2011, Blood reviews.
[20] Frank E. Harrell,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .
[21] D. Rossi,et al. Richter syndrome: molecular insights and clinical perspectives , 2009, Hematological oncology.
[22] P. Grambsch,et al. Martingale-based residuals for survival models , 1990 .
[23] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[24] I. Screpanti,et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B‐CLL , 2010, British journal of haematology.
[25] L. Medeiros,et al. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma , 2013 .
[26] K. Maloum,et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. , 1998, The New England journal of medicine.
[27] D. Rossi,et al. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness , 2009, Clinical Cancer Research.
[28] F. Mancini,et al. White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia , 2011, Haematologica.
[29] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[30] References , 1971 .
[31] E. Montserrat,et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. , 2005, Blood.
[32] S. Stilgenbauer,et al. Understanding and managing ultra high-risk chronic lymphocytic leukemia. , 2010, Hematology. American Society of Hematology. Education Program.
[33] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[34] J F Lawless,et al. Regression and recursive partition strategies in the analysis of medical survival data. , 1988, Journal of clinical epidemiology.
[35] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[36] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[37] E. Kimby,et al. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus , 2007, Leukemia.
[38] Deborah A. Bowen,et al. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia , 2010, Cancer.
[39] E. Giné,et al. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. , 2009, Blood.
[40] T. Haferlach,et al. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype , 2009, Leukemia.
[41] D.,et al. Regression Models and Life-Tables , 2022 .
[42] M. Hallek,et al. Prognostic factors in chronic lymphocytic leukemia—what do we need to know? , 2011, Nature Reviews Clinical Oncology.
[43] W. Grody,et al. [Diffuse large B-cell lymphoma]. , 2006 .
[44] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[45] N. Chiorazzi,et al. mechanisms of disease Chronic Lymphocytic Leukemia , 2010 .
[46] Susan Slager,et al. Validation of a new prognostic index for patients with chronic lymphocytic leukemia , 2009, Cancer.
[47] Francesco Bertoni,et al. Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome , 2009, Clinical Cancer Research.
[48] A Benner,et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. , 1995, Blood.
[49] T. Hamblin,et al. Chronic lymphocytic leukaemia , 2008, The Lancet.
[50] Natural history of stage A chronic lymphocytic leukaemia untreated patients , 1990, British journal of haematology.
[51] A. Tsimberidou,et al. Richter syndrome , 2005, Cancer.
[52] J. C. van Houwelingen,et al. Predictive value of statistical models , 1990 .
[53] A. Favero,et al. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies , 1990, British journal of haematology.
[54] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[55] Kim-Anh Do,et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. , 2007, Blood.
[56] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.